Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes

NCT03967938 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

540

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers Harbouring Mutations in HRG

Interventions

DRUG: Olaparib Oral Capsule

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

[object Object]
[object Object]